Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers

NCT05379972 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer
GastroEsophageal Cancer

Interventions

DRUG: Pembrolizumab
DRUG: Olaparib
RADIATION: Stereotactic Body Radiation Therapy

Sponsor

University of Colorado, Denver

Collaborators

[object Object]